Cisplatin Market Analysis Application (Oncology, Non-Oncology), Type of Cancer (Lung cancer, Ovarian cancer, Testicular cancer, Others), End-User (Hospitals, Cancer Treatment Centers, Research Institutes), Distribution Channel (Pharmaceutical wholesalers, Direct sales to hospitals, Online pharmacies) and by Region: Global Forecast, 2025 - 2035.
- PUBLISHED ON
- 2025-01-23
- NO OF PAGES
- 231
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Cisplatin market is predicted to develop at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2035, when it is projected to reach USD 28.54 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 14.46 Billion in 2025.
SOURCE: We Market Research
Cisplatin is a
chemotherapy medication used to treat a variety of cancers, including
testicular, ovarian, bladder, lung, cervical, and head and neck cancer. When
administered intravenously in therapeutic settings, it inhibits cancer cell
proliferation, resulting in their death. Despite its effectiveness, cisplatin
can cause nausea, vomiting, kidney impairment, hearing loss, and nerve damage
because it affects healthy cells. As a result, its use necessitates close
monitoring by healthcare specialists to manage these side effects. Cisplatin is
frequently used with other chemotherapeutic medicines to improve cancer
patients' treatment outcomes, highlighting the necessity of customized cancer
care.
A popular
chemotherapy medication, cisplatin is in high demand for a variety of reasons.
Increased cancer incidence rates, particularly in older populations, are the
driving force behind its usage, which is also made possible by improvements in
cancer therapy and early detection programs. Favorable reimbursement and
regulatory frameworks promote its use, and advancements in technology enhance
its efficacy and safety. Expanded healthcare infrastructures, particularly in
developing countries, enable more access to cisplatin-based treatments.
Collaborations and partnerships in the healthcare sector expedite research and
development and result in novel product formulations and applications. These
factors contribute to the expansion and significance of cisplatin in cancer
therapy and highlight the critical role that it plays in patient care.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2025 |
USD 14.46 Billion |
|
Market Forecast in 2035 |
USD 28.54 Billion |
|
CAGR % 2025-2035 |
8.3% |
|
Base Year |
2024 |
|
Historic Data |
2021-2024 |
|
Forecast Period |
2025-2035 |
|
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
by Application, by Type of Cancer, by End-User, by Distribution
Channel and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Cisplatin Industry: Dynamics & Restrains
We Market Research: Cisplatin Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Cisplatin Segmentation
Market- By Application Analysis
By Application, the Cisplatin Market is Categories into Oncology, Non-Oncology. The Oncology segment accounts for the largest share of around 68% in 2024.
Cisplatin is a key component of oncology
treatment plans for a number of cancers, including lung, ovarian, testicular,
and bladder tumors. Demand is driven by its effectiveness in stopping DNA
replication in cancer cells, particularly in combination medicines that improve
the prognosis of cancer treatment.
The
following segments are part of an in-depth analysis of the global Cisplatin
market:
|
Market Segments |
|
|
By Type
of Cancer |
·
Lung cancer ·
Ovarian cancer ·
Testicular cancer ·
Others |
|
By End-User |
·
Hospitals ·
Cancer Treatment Centers ·
Research Institutes |
|
By Distribution
Channel |
·
Pharmaceutical wholesalers ·
Direct sales to hospitals ·
Online pharmacies |
Cisplatin Industry: Regional Analysis
Asia Pacific Market Forecast
Asia Pacific dominate the Cisplatin Market with the highest revenue generating market with share of more than 47%. The market for cisplatin in Asia Pacific is dominated due to a number of factors, including an aging population, a growing middle class, rising cancer awareness, better access to healthcare, and rising investments in healthcare infrastructure.
North America Market Statistics
North America is second largest market for Cisplatin due to Presence of established pharmaceutical companies, high prevalence of cancer, advanced healthcare infrastructure, and strong R&D investments drive demand for cisplatin in cancer treatment.
Europe Market Forecasts
Europe is
expected to be the fastest-growing regional segment of the Cisplatin market
during the forecast period. In the Europe, increasing cancer incidence,
supportive regulatory environment, growing adoption of novel therapies
incorporating cisplatin, and emphasis on personalized medicine contribute to
market growth.
Key Market Players
The Cisplatin
Market is dominated by a few large companies, such as
·
Pfizer
·
Eli Lilly and Company
·
David Bull Laboratories
·
Hospira
·
Bedford Pharmaceuticals
·
West-Ward Pharmaceuticals
·
Athenex Pharmaceutical
·
WG Critical Care
·
Alvogen
·
Gland Pharma (Fosun Pharma)
·
Yunnan Biological Valley
Pharmaceutical
· Jiangsu Haosen Pharmaceutica
· Other
1.
Global
Cisplatin Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Cisplatin Market Scope
and Market Estimation
1.2.1. Global Cisplatin Overall Market
Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Cisplatin Market Revenue
Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Component of Global Cisplatin
Market
1.3.2. Technology of Global Cisplatin
Market
1.3.3. End-user of Global Cisplatin
Market
1.3.4. Region of Global Cisplatin
Market
2.
Executive Summary
2.1. Global Cisplatin Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Cisplatin Market
Industry Development
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and Restraints
2.3. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6. Value Chain / Ecosystem Analysis
2.7. Russia-Ukraine War Impacts
Analysis
2.8. Economic Downturn Analysis
2.9. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Cisplatin Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Cisplatin Market Estimates & Forecast Trend Analysis, by
TYPE OF CANCER
4.1. Global Cisplatin Market Revenue
(US$ Mn) Estimates and Forecasts, by TYPE OF CANCER, 2019 to 2034
4.1.1. Lung cancer
4.1.2. Ovarian cancer
4.1.3. Testicular cancer
4.1.4. Others
5.
Global Cisplatin Market Estimates & Forecast Trend Analysis, by
Application
5.1. Global Cisplatin Market Revenue
(US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
5.1.1. Oncology
5.1.2. Non-Oncology
6.
Global Cisplatin Market Estimates & Forecast Trend Analysis, by
End-user
6.1. Global Cisplatin Market Revenue
(US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034
6.1.1. Hospitals
6.1.2. Cancer Treatment Centers
6.1.3. Research Institutes
7.
Global Cisplatin Market Estimates & Forecast Trend Analysis, by
DISTRIBUTION CHANNEL
7.1. Global Cisplatin Market Revenue
(US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034
7.1.1. Pharmaceutical wholesalers
7.1.2. Direct sales to hospitals
7.1.3. Online pharmacies
8.
Global Cisplatin Market Estimates & Forecast Trend Analysis,
by Region
8.1. Global Cisplatin Market Revenue
(US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9.
North
America Cisplatin Market: Estimates & Forecast Trend Analysis
9.1.
North
America Cisplatin Market Assessments & Key Findings
9.1.1. North America Cisplatin Market
Introduction
9.1.2. North America Cisplatin Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1. By TYPE OF CANCER
9.1.2.2. By Application
9.1.2.3. By End-user
9.1.2.4. By DISTRIBUTION
CHANNEL
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Europe Cisplatin
Market: Estimates & Forecast Trend
Analysis
10.1. Europe Cisplatin Market
Assessments & Key Findings
10.1.1. Europe Cisplatin Market
Introduction
10.1.2. Europe Cisplatin Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By TYPE OF CANCER
10.1.2.2. By Application
10.1.2.3. By End-user
10.1.2.4. By DISTRIBUTION
CHANNEL
10.1.2.5. By Country
10.1.2.5.1. Germany
10.1.2.5.2. U.K.
10.1.2.5.3. France
10.1.2.5.4. Italy
10.1.2.5.5. Spain
10.1.2.5.6. Russia
10.1.2.5.7. Rest of Europe
11. Asia Pacific Cisplatin
Market: Estimates & Forecast Trend
Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1. Asia Pacific Cisplatin Market
Introduction
11.1.2. Asia Pacific Cisplatin Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By TYPE OF CANCER
11.1.2.2. By Application
11.1.2.3. By End-user
11.1.2.4. By DISTRIBUTION
CHANNEL
11.1.2.5. By Country
11.1.2.5.1. China
11.1.2.5.2. Japan
11.1.2.5.3. India
11.1.2.5.4. Australia
11.1.2.5.5. South Korea
11.1.2.5.6. ASEAN
11.1.2.5.7. Rest of Asia Pacific
12. Middle East & Africa Cisplatin
Market: Estimates & Forecast Trend
Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1. Middle
East & Africa Cisplatin
Market Introduction
12.1.2. Middle
East & Africa Cisplatin
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By TYPE OF CANCER
12.1.2.2. By Application
12.1.2.3. By End-user
12.1.2.4. By DISTRIBUTION
CHANNEL
12.1.2.5. By Country
12.1.2.5.1. U.A.E.
12.1.2.5.2. Saudi Arabia
12.1.2.5.3. Egypt
12.1.2.5.4. South Africa
12.1.2.5.5. Rest of Middle East & Africa
13. South America
Cisplatin Market: Estimates &
Forecast Trend Analysis
13.1. South America Market Assessments
& Key Findings
13.1.1. South America Cisplatin Market
Introduction
13.1.2. South America Cisplatin Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
13.1.2.1. By TYPE OF CANCER
13.1.2.2. By Application
13.1.2.3. By End-user
13.1.2.4. By DISTRIBUTION
CHANNEL
13.1.2.5. By Country
13.1.2.5.1. Brazil
13.1.2.5.2. Argentina
13.1.2.5.3. Colombia
13.1.2.5.4. Rest of South America
14. Competition Landscape
14.1. Global Cisplatin Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
14.2. Global Cisplatin Market
Competition White Space Analysis, By End-user
14.3. Global Cisplatin Market
Competition Heat Map Analysis, By End-user
14.4. Global Cisplatin Market
Concentration & Company Market Shares (%) Analysis, 2022
15. Company Profiles
15.1.
Pfizer
15.1.1. Company Overview & Key Stats
15.1.2. Financial Performance & KPIs
15.1.3. Product Portfolio
15.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
15.2. Eli Lilly and
Company
15.3. David Bull
Laboratories
15.4. Hospira
15.5. Bedford
Pharmaceuticals
15.6. West-Ward
Pharmaceuticals
15.7. Athenex
Pharmaceutical
15.8. WG Critical
Care
15.9. Alvogen
15.10. Gland Pharma
(Fosun Pharma)
15.11. Yunnan
Biological Valley Pharmaceutical
15.12. Jiangsu Haosen
Pharmaceutica
15.13. Other
16. Research
Methodology
16.1. External Transportations /
Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Cisplatin Market in 2025?
Cisplatin Market was valued at USD 14.46 Billion in 2025.
What is the growth rate for the Cisplatin Market?
Cisplatin Market size will increase at approximate CAGR of 8.3% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Cisplatin Market Are Pfizer, Eli Lilly and Company, David Bull Laboratories, Hospira, Bedford Pharmaceuticals, West-Ward Pharmaceuticals, Athenex Pharmaceutical, WG Critical Care, Alvogen, Gland Pharma (Fosun Pharma), Yunnan Biological Valley Pharmaceutical, Jiangsu Haosen Pharmaceutica and Other.
Which region dominates the Cisplatin Market?
Asia Pacific dominates the market with an active share of 47%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI